APRILBIO CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15,030 KRW | -0.86% |
|
+0.20% | -10.80% |
| Sales 2023 | - | Sales 2024 * | 22.5B 16.24M 1.36B | Capitalization | 326B 236M 19.67B |
|---|---|---|---|---|---|
| Net income 2023 | -14B -10.11M -843M | Net income 2024 * | -10B -7.22M -602M | EV / Sales 2023 | - |
| Net cash position 2023 * | 85B 61.37M 5.12B | Net cash position 2024 * | 82B 59.2M 4.94B | EV / Sales 2024 * | 10.9 x |
| P/E ratio 2023 |
-22.7
x | P/E ratio 2024 * |
-33
x | Employees | - |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 69.14% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.86% | ||
| 1 week | +0.20% | ||
| Current month | -8.19% | ||
| 1 month | -8.19% | ||
| 3 months | +11.91% | ||
| 6 months | +39.17% | ||
| Current year | -10.80% |
1 week
14 800.00
15 600.00
1 month
13 670.0017 450.00
Current year
11 510.0019 150.00
1 year
9 115.0019 150.00
3 years
5 200.0019 150.00
5 years
5 200.0019 150.00
10 years
5 200.0019 150.00
| Managers | Title | Age | Since |
|---|---|---|---|
Sang-Hun Cha
FOU | Founder | 61 | 12/13/12 |
Jin-Taek Kim
DFI | Director of Finance/CFO | 53 | - |
Moo-Young Song
CTO | Chief Tech/Sci/R&D Officer | 57 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sang-Hun Cha
FOU | Founder | 61 | 12/13/12 |
Jin-Taek Kim
DFI | Director of Finance/CFO | 53 | - |
Eun-Jik Lee
BRD | Director/Board Member | 65 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/24/30 | 15,030 | -0.86% | 111 003 |
| 29/24/29 | 15,160 | +0.86% | 113,539 |
| 26/24/26 | 15,030 | +0.20% | 112,242 |
| 25/24/25 | 15,000 | -2.53% | 153,038 |
| 24/24/24 | 15,390 | -0.39% | 206,256 |
End-of-day quote Korea S.E., April 30, 2024
More quotes
AprilBio Co Ltd is a Korea-based company primarily engaged in the biological drug development business. The Company is primarily engaged in the bio-innovative new drug research and development (R&D) business such as antibody therapeutics and long-acting recombinant protein pharmaceuticals.
Calendar
10/05/2024
- Q1 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
15,030
KRW
Average target price
27,000
KRW
Spread / Average Target
+79.64%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -10.80% | 239M | |
| -3.46% | 102B | |
| +1.41% | 96.29B | |
| +2.13% | 22.18B | |
| -15.84% | 21.2B | |
| -9.21% | 18.31B | |
| -39.98% | 17.38B | |
| -14.65% | 16.36B | |
| +4.39% | 13.97B | |
| +31.35% | 12.17B |
- Stock Market
- Equities
- A397030 Stock
